Pure Global

Long-acting reversible contraception (LARC) - Trial PACTR201701001898417

Access comprehensive clinical trial information for PACTR201701001898417 through Pure Global AI's free database. This Not Applicable trial is sponsored by Faculty of Medicine and is currently Completed. The study focuses on Pregnancy and Childbirth; Other.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
PACTR201701001898417
Not Applicable
Completed
other
Trial Details
Pan Africa Clinical Trials Registry • PACTR201701001898417
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Long-acting reversible contraception (LARC)
Impact of Implanon versus Depot-medroxyprogesterone acetate injection on menstrual changes and uterine artery Doppler indices: a randomized clinical trial

Study Focus

other

Sponsor & Location

Faculty of Medicine

Menoufia governorate

Egypt

Timeline & Enrollment

Not Applicable

Dec 14, 2016

Aug 18, 2017

Summary

to assess the impact of Implanon versus Depot-medroxyprogesterone acetate injection on menstrual changes and uterine artery Doppler waveforms.

ICD-10 Classifications

Pregnancy, childbirth and the puerperium
Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery
Fetus and newborn affected by other complications of labour and delivery
Fetus and newborn affected by other specified complications of labour and delivery
Fetus and newborn affected by other maternal complications of pregnancy

Data Source

Pan Africa Clinical Trials Registry

PACTR201701001898417

Non-Device Trial